Correlation Between Visa and BioLine RX

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and BioLine RX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and BioLine RX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and BioLine RX, you can compare the effects of market volatilities on Visa and BioLine RX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of BioLine RX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and BioLine RX.

Diversification Opportunities for Visa and BioLine RX

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Visa and BioLine is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and BioLine RX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLine RX and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with BioLine RX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLine RX has no effect on the direction of Visa i.e., Visa and BioLine RX go up and down completely randomly.

Pair Corralation between Visa and BioLine RX

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.11 times more return on investment than BioLine RX. However, Visa Class A is 8.9 times less risky than BioLine RX. It trades about 0.04 of its potential returns per unit of risk. BioLine RX is currently generating about -0.42 per unit of risk. If you would invest  31,771  in Visa Class A on October 21, 2024 and sell it today you would earn a total of  191.00  from holding Visa Class A or generate 0.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy84.21%
ValuesDaily Returns

Visa Class A  vs.  BioLine RX

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in February 2025.
BioLine RX 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLine RX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Visa and BioLine RX Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and BioLine RX

The main advantage of trading using opposite Visa and BioLine RX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, BioLine RX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLine RX will offset losses from the drop in BioLine RX's long position.
The idea behind Visa Class A and BioLine RX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk